6-oxo-1, 6-dihydropyridine derivatives, pentachloroethylene inhibitors reconstituted during blood transfusion, pharmaceutical ingredients, and compounds used to treat prone bowel and CCER catheters.
The invention refers to a new compound of pentagonase inhibitor which is reconstituted in the process of transfer.Pharmaceutical ingredients containing these substances, their preparation procedures, and procedures used alone or in combination for treatment to standardize the treatment of gastrointestinal sensitivity, motility and / or secretion normalization and / or abdominal disorders or diseases and / or disorders related to functional disorders Where the modulation of RET or RET activity can bring therapeutic benefits, the modulation of RET activity may include, but is not limited to, all categories of intestinal flammability sindrome (SII), including major diarrhea, major constipation as alternating feces, functional abdominal relaxation, and functional constipation,Functional diarrhea functional bowel disorder functional abdominal pain Symphony Chronic psychosis, functional esophageal disorder, functional gastrointestinal disorder, functional anorexic pain, intestinal inflammation, and diffuse diseases, such as non-small cell lung cancer, liver cancer, rectal cancer, and spinal cord thyroid cancer, Leaf thyroid cancer, anaerobic thyroid cancer, mumps thyroid cancer, brain tumor, peritoneal cavity cancer, solid tumor, another lung cancer, head and neck cancer, blood cell, neuroma,SYNDROME OF VON HIPPEL-LINDAU AND TUMORES DE RIÑON, CANCER DE MAMA, CANCER OF THE TRUMPES OF FALOPIO, CANCER OF OVARIO, CANCER OF TRANSITIONAL CELLS, CANCER OF PROSTATE, CANCER OF ESOPHAGO AND CANCERARA YAQUEA, GASTROESAR YICA ANY EVIL TUMOR WITH AN INCREASE IN THE ACTIVITY QUINASA RET.ESTA INVENCIÔN SE REFIERE A NUEVOS COMPUESTOS QUE SON INHIBIDORES DE LA QUINASA REORGANIZADA DURANTE LA TRANSFECCION (RET), A COMPOSICIONES FARMACÉUTICAS QUE LOS CONTIENEN, A LOS PROCEDIMIENTOS PARA SU PREPARACIÓN, Y A SU USO EN TERAPIA, SOLOS O COMBINADOS, PARA LA NORMALIZACION DE LA SENSIBILIDAD, LA MOTILIDAD Y/O LA SECRECIÓN GASTROINTESTINALES Y/O TRASTORNOS O ENFERMEDADES ABDOMINALES Y/O EL TRATAMIE
